• Ph.D. in Mathematical Biology - Hebrew University of Jerusalem, Israel and Université Libre, Brussels, Belgium.
• M.Sc. in Genetics- Hebrew University of Jerusalem, Israel
• President of the Israeli Society for Theoretical and Mathematical Biology.
• Member of the Board of the European Society for Mathematical and Theoretical Biology ESMTB).
• Founder and president of the Institute for Medical Biomathematics (IMBM)
• Founder and chairperson of Optimata Ltd.
• Associate Editor of Wiley Series in Mathematical and Computational Biology.
• Associate Editor of the Journal of Biological Systems.
• Associate Editor - Journal of Mathematical Models and Methods in Applied Sciences (M3AS).

Karin holds a Ph.D. degree in Molecular Biology from the Weizmann Institute of Science Rehovot. Her Ph.D. thesis, in the field of molecular and cellular biology, focused on the proto-oncogene c-Myc as a transcription factor and inducer of apoptosis and on the control of c-Myc degradation. She worked for more than ten years in biotechnology start-up companies in the fields of drug discovery and drug development. Karin joined IMBM in January 2008. At IMBM she takes part in two projects:.
Modeling of main intracellular signalling pathways controlling stem cell and Modeling of prostate cancer vaccine.

Natalie joined IMBM in March 2005 as a fellow of the Marie Curie research project MRTN-CT-204-503661, "Using mathematical and computer simulation to improve cancer therapy". She holds a Ph.D. in Plant Sciences from Tel Aviv University; her thesis was titled "Differentiation of the vascular system in conifers". She also holds a Ph.D. from the University of Minnesota; her thesis, titled "Evolutionary games in space", introduces spatial effects into game-theory–based evolutionarily stable strategies (ESS). The thesis was completed in the framework of the Conservation Biology graduate program at the University of Minnesota. At IMBM Natalie is involved in the malignant gliomas immunotherapy project as well as in the NEST Cancer Stem Cells project.

Lilach has completed her Ph.D. studies at the Weizmann institute of science under the supervision of Prof. Moti Liscovitch in the department of biological regulation. Her thesis work has focused on experimentally studying the molecular mechanisms of caveolin-1 induction by PPAR? ligands in human cancer cells. She holds B.Sc. and M.Sc. degrees from Tel-Aviv University, Faculty of Life Science. Her M.Sc. work in the department of Biochemistry focused on how immunoglobulin light chains dictate vesicular transport-dependent and independent routes for IgM degradation by the ubiquitin-proteasome pathway.

Vladimir is a Medical Doctor at the Hadassah Medical Center in Jerusalem. He holds a B.Sc. degree in Medical Sciences from the Hebrew University, M.D. degree from the Hebrew University / Hadassah Medical School, and an M.Sc. degree from the Department of Experimental Medicine and Cancer Research in the faculty of Medicine at the Hebrew University of Jerusalem. His M.Sc. research, carried out under the supervision of Prof. S.A. Ben-Sasson, involved the use of pathway inhibitors for the C-terminal post-translational modification of proteins as a possible avenue for developing anti-angiogenesis therapy. Dr Vainstein is a fellow in the Internal medicine Department at Hadassah Medical Center, Campus Mt. Scopus, Jerusalem. At IMBM he takes part in the immunotherapy project, developing methods for improving the efficacy of monoclonal antibody drugs by mathematically modeling the effects of such drugs on target and immune cells, and investigating data of survival of patients with myelodysplastic syndrome to better understand the pathophysiology of this disease by mathematical methods.

Moran joined IMBM in November 2004, after completing a B.Sc. in Computational Biology at Bar-Ilan University. At IMBM, Moran takes part in the Cancer Immunotherapy project. She is also a third-year direct Ph.D. student in the Faculty of Medicine at the Hebrew University of Jerusalem, under the supervision of Prof. Francesca Levi-Schaffer.

After completing his B.Sc. in Life Science and Mathematics at the Hebrew University of Jerusalem, Yuri spent two more years at the Hebrew University studying Near Field microscope applications to micro-manipulations in biophysics under the supervision of Prof Aharon Lewis (see 1). Yuri holds an M.Sc. degree in Applied Mathematics from the Technion, Israel Institute of Technology. His M.Sc. study involved mathematical combustion theory. At IMBM Yuri employs his skills in applied mathematics for developing mechanism-based models of cancer drug therapy and its accompanying physiological side effects.

Yuri holds a BA degree in Theoretical Mathematics from the Tel-Aviv University. Over many years of scientific research, he has been involved in biomathematical modeling of several cancer diseases, as well as in cancer stem cell research, intracellular signal transduction and clinical immunotherapy. His current research at IMBM is focused on modeling cancer growth and treatment, in particular immunotherapy of prostate cancer and glioblastomas, modeling cancer stem cells, and modeling intracellular signal transduction. Scientific Activities

Ofir holds a B.Sc. degree from Holon Institute for Technology (H.I.T), Department of Applied Mathematics. He majored in Biomathematics and in Signal Processing. Ofir currently pursues a M.Sc. degree in Applied Mathematics at the University of Tel-Aviv, focusing his thesis on image processing. At IMBM Ofir is involved in researching the transformation of myelodysplastic syndrome (MDS) to acute myeloid leukemia (AML). He is also involved in devising medical imaging algorithms. Scientific Activities

Dorit is the Administrative Manager of IMBM. She holds a B.A. degree in English Literature and Information Science from Bar–Ilan University. Her primary responsibility is providing quality services to ensure successful finance and personnel management of IMBM members and visitors. The latter include Israeli and foreign scientists and students, engineering trainees, as well as post-doctorate students at IMBM. Dorit serves as administrative officer of two European research projects Marie Curie and NEST. The administrative unit supports the scientific activities and enables the wide base on which research is accomplished. In addition, Dorit acts as the administrator of the non-profit organization (which is the legal status of IMBM). She is in charge of organizing board meetings, preparing board minutes, budget and annual reports to the authorities involving the association Lawyers and accountants. The Administrator organizes and oversees the logistical activities in the office, procurement activities and staff workload oversight.

About IMBM | Scientific Board | IMBM Members | Research Projects | Applications
Join Us | Press Release | Events | Publications | HOME